Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CORTEVA, INC.

(CTVA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Corteva : Raises Quarterly Dividend to $0.14 a Share From $0.13, Payable Sept. 15 to Shareholders of Record Aug. 13

07/21/2021 | 10:37am EDT


© MT Newswires 2021
All news about CORTEVA, INC.
09/08CORTEVA : Agreement with Gaïago to Develop and Distribute Biofungicide Solutions
PU
09/07CORTEVA : Three conversation starters to use at the farmers market
PU
09/01CORTEVA : Berenberg Starts Corteva at Buy With $58 Price Target
MT
08/31CORTEVA : Licenses Elemental Enzymes' Peptide Technology for New Fungicide
MT
08/31CORTEVA : Survey Reveals Farmer Sentiment on Soil Health and Carbon Credit Progr..
PU
08/31CORTEVA : Expands Agreement with Elemental Enzymes
PU
08/30CORTEVA : and Plantix Introduce Free Pest, Disease and Weed Identification App
PU
08/26BARCLAYS : Corteva, Indigo Ag team up on carbon credit program for U.S. farmers
RE
08/26CORTEVA : Announces Expansion of Corteva Carbon Initiative for 2022 Crop Year
PU
08/26BAYER : Syngenta Group benefits from farmers restocking as Q2 sales rise 28%
RE
More news
Analyst Recommendations on CORTEVA, INC.
More recommendations
Financials (USD)
Sales 2021 15 293 M - -
Net income 2021 1 232 M - -
Net cash 2021 2 146 M - -
P/E ratio 2021 23,9x
Yield 2021 1,33%
Capitalization 30 740 M 30 740 M -
EV / Sales 2021 1,87x
EV / Sales 2022 1,76x
Nbr of Employees 21 000
Free-Float 99,9%
Chart CORTEVA, INC.
Duration : Period :
Corteva, Inc. Technical Analysis Chart | CTVA | US22052L1044 | MarketScreener
Technical analysis trends CORTEVA, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 41,87 $
Average target price 50,63 $
Spread / Average Target 20,9%
EPS Revisions
Managers and Directors
James C. Collins Chief Executive Officer & Director
David John Anderson Chief Financial Officer & Executive Vice President
Gregory R. Page Non-Executive Chairman
Debra King Chief Information Officer & Senior Vice President
Sam Eathington Chief Technology Officer & Senior Vice President
Sector and Competitors